Treatment of type 2 diabetes with glitazones - first do no harm?

Christoph Henzen

doi:10.4414/smw.2009.12659

Viewpoint

Vol. 139 No. 1112 (2009)

Treatment of type 2 diabetes with glitazones - first do no harm?

Christoph Henzen

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2009.12659
Cite this as:: Swiss Med Wkly. 2009;139:154-154
Published: 21.03.2009

How to Cite

1.

Henzen C. Treatment of type 2 diabetes with glitazones - first do no harm?. Swiss Med Wkly [Internet]. 2009 Mar. 21 [cited 2024 Apr. 19];139(1112):154-. Available from: https://smw.ch/index.php/smw/article/view/959

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Brigitta Zumbrunn, Odile Stalder, Andreas Limacher, Peter E. Ballmer, Stefano Bassetti, Edouard Battegay, Jürg Hans Beer, Michael Brändle, Daniel Genné, Daniel Hayoz, Christoph Henzen, Lars Christian Huber, Pierre-Auguste Petignat, Jean-Luc Reny, Peter Vollenweider, Drahomir Aujesky, The well-being of Swiss general internal medicine residents , Swiss Medical Weekly: Vol. 150 No. 2324 (2020)
Stefan Fischli, Barbara Lucchini, Werner Müller, Lea Slahor, Christoph Henzen, Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves’ disease , Swiss Medical Weekly: Vol. 146 No. 0102 (2016)
Christoph Henzen, Monogenic diabetes mellitus due to defects in insulin secretion , Swiss Medical Weekly: Vol. 142 No. 3940 (2012)
Sven Berkmann, Javier Fandino, Beat Müller, Karl F Kothbauer, Christoph Henzen, Hans Landolt, Pituitary surgery: experience from a large network in Central Switzerland , Swiss Medical Weekly: Vol. 142 No. 3940 (2012)
Sven Berkmann, Javier Fandino, Beat Müller, Karl F. Kothbauer, Christoph Henzen, Hans Landolt, Reply to the Letter to the Editor “Visual outcomes after pituitary surgery” , Swiss Medical Weekly: Vol. 143 No. 2122 (2013)